In late July, The Economist declared that there is “no better example” of Britain’s strengths than the life sciences sector. To what extent have the government's ambitions translated into action?
Public Policy Projects
As the wheels of integrated care begin to turn, Eliot Gillings explores exactly what integrated care partnerships should be prioritising, and why.
Public Policy Projects
Personal comments by Jon Gibbins, Professor of Carbon Capture and Storage, University of Sheffield and Director, UK CCS Research Centre, on the need for change.
Public Policy Projects
On 25th July, the Health and Social Care Committee (HSCC) published their report, Workforce: recruitment, training and retention in health and social care.
Public Policy Projects
While there is a broad consensus that the UK needs to improve the efficiency of its food system – and that the implementation of novel technologies in farming practices and across the food system is the most efficient route – it is unclear how to make this happen. While the UK is a global R&D power, too often new advances have not made it far enough along the innovation pathway to be implemented in commercial practices in the UK.
Public Policy Projects
See news:
News articles
In late July, The Economist declared that there is “no better example” of Britain’s strengths than the life sciences sector. To what extent have the government's ambitions translated into action?
As the wheels of integrated care begin to turn, Eliot Gillings explores exactly what integrated care partnerships should be prioritising, and why.
Personal comments by Jon Gibbins, Professor of Carbon Capture and Storage, University of Sheffield and Director, UK CCS Research Centre, on the need for change.
On 25th July, the Health and Social Care Committee (HSCC) published their report, Workforce: recruitment, training and retention in health and social care.
While there is a broad consensus that the UK needs to improve the efficiency of its food system – and that the implementation of novel technologies in farming practices and across the food system is the most efficient route – it is unclear how to make this happen. While the UK is a global R&D power, too often new advances have not made it far enough along the innovation pathway to be implemented in commercial practices in the UK.
Carbon capture, utilisation and storage (CCUS) and carbon removals are important technologies for the decarbonisation of the energy sector in the long-term.
A new report from Public Policy Projects (PPP) has found that standards of care for those living with rare diseases in the UK fall below government commitments set out in its England Rare Diseases Action Plan 2022.
On 22nd June 2022, Public Policy Projects (PPP) hosted a roundtable entitled A Care System for the Future: Digital Opportunities and the Arrival of Caretech. The discussion saw PPP's Social Care Network explore some of the challenges around digitising and integrating care, as well as the roles of government and the social care sector in facilitating the transformation towards a technology-driven, but person-led, social care system.
The introduction of a gene-editing bill to parliament on 25th May marked a monumental step in the post-Brexit era. Since 2018, it has been nearly impossible to grow gene-edited food in the EU at a commercial scale. However, now free to make its own regulations, the UK is seizing the chance to unlock its significant R&D infrastructure and reap the security and nutritional benefits of gene-editing.
Agrifood encompasses the entire food supply chain, from agriculture production to food consumption. Every human is a stakeholder in the agrifood system and supply chain, as they are all elements of the natural environment.
A new fund to boost life science innovation was revealed by Sir Jon Symonds at the Global Genomics Conference, as the current Chairman of GSK hinted at a raft of upcoming major policy proposals for life sciences and genomics.
Despite its size, Iceland has emerged as a pioneer of carbon capture and storage (CCS) technologies. As part of the Pathway to COP programme, the World Economic Series (WES) hosted by PPP and Diplomat Magazine explored how Iceland’s experience can inform other countries seeking to develop carbon management strategies – and how they can further collaborate in their efforts.
With the advanced therapy and medicinal product (ATMP) landscape looking positive, Public Policy Projects are exploring the challenges to gene and cell therapy adoption and how the UK can build upon its successes in the post-pandemic environment.
Lack of diversity in genomics is incompatible with a healthy world, say global genomic experts at a recent Public Policy Projects (PPP) webinar.
With the Telomere2Telomere Consortium’s publishing the first complete human genome, research into telomeres and genomic sequencing could have profound impacts on healthcare around the globe.
World Health Day 2022 reflects on another year of grappling loss from the pandemic, observing an increasingly polluted planet, and witnessing the uninvited increase in disease prevalence.
At Conservative Party Conference 2021, Public Policy Projects brought together stakeholders to discuss the increasingly important role of UK life sciences in the government's leveling up agenda.
As debate over the Northern Ireland Protocol continues, the World Economic Series’ most recent event at the Mansion House, presented by Public Policy Projects (PPP) and Diplomat Magazine, offered a rare opportunity for representatives of both the UK and Ireland to clarify their respective positions and perspectives.
Public Policy Projects (PPP) is delighted to announce the launching of its 2022 Rare Disease program, co-chaired by Alastair Kent OBE, independent patient advocate, and Dr Shehla Mohammed, Guy’s and St Thomas’ NHS Foundation Trust; supported by Cognitant.
Opportunity, optimism and challenge – all key themes highlighted in IQVIA’s Annual Life Sciences Innovation Summit, where some of the industry’s leading life science experts called for the UK to become a life science “superpower. ”